Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Total Non-Current Liabilities (2018 - 2025)

TELA Bio (TELA) has 8 years of Total Non-Current Liabilities data on record, last reported at $58.5 million in Q3 2025.

  • For Q3 2025, Total Non-Current Liabilities rose 1.11% year-over-year to $58.5 million; the TTM value through Sep 2025 reached $58.5 million, up 1.11%, while the annual FY2024 figure was $56.7 million, 1.32% down from the prior year.
  • Total Non-Current Liabilities reached $58.5 million in Q3 2025 per TELA's latest filing, up from $57.1 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $58.5 million in Q3 2025 and bottomed at $36.6 million in Q1 2021.
  • Average Total Non-Current Liabilities over 5 years is $51.6 million, with a median of $55.0 million recorded in 2022.
  • Peak YoY movement for Total Non-Current Liabilities: surged 35.11% in 2022, then fell 1.32% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $42.1 million in 2021, then increased by 24.37% to $52.3 million in 2022, then rose by 9.87% to $57.5 million in 2023, then dropped by 1.32% to $56.7 million in 2024, then rose by 3.08% to $58.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $58.5 million in Q3 2025, $57.1 million in Q2 2025, and $57.8 million in Q1 2025.